119th Congress

H.R. 9699

Drug Deal Disclosure Act

Introduced
In committee
Passed House
Passed Senate
To President
Became law

Sponsor: Judy Chu(D-CA)
Introduced: Jul 15, 2026
Policy area: Health
Committees: House Committee on Energy and Commerce; House Committee on the Budget; House Committee on Ways and Means
Official text: Introduced in House · Congress.gov page

Cosponsors (24)

Original cosponsors (23)

Added later (1)

Paul Tonko (D-NY) · Jul 16, 2026

Summary

No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.

Official title: To require the Department of Health and Human Services to release documents, communications, and other information relating to most favored nation pricing agreements and other private or confidential drug pricing deals struck with manufacturers, and for other purposes.

Latest action(Jul 15, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the official text

Roll-call votes

No recorded votes on this bill.

Actions

Jul 15, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 15, 2026
Introduced in House